Joseph Nowell
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Advances in the drug treatment of Alzheimer's disease: pathophysiology and mechanisms of action.
Journal: BMJ (Clinical research ed.)
Published: April 21, 2026
Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial.
Journal: Nature medicine
Published: June 17, 2025
Do Tau Deposition and Glucose Metabolism Dissociate in Alzheimer's Disease Trajectory?
Journal: Journal of Alzheimer's disease : JAD
Published: September 20, 2024
Nasal dominance potentiates intranasal oxytocin's anxiolytic effects.
Journal: Scientific reports
Published: March 26, 2024
Cardiovascular risk and obesity impact loss of grey matter volume earlier in males than females.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: February 25, 2024
Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease.
Journal: Ageing research reviews
Published: January 25, 2023
Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease.
Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease.
Journal: Molecular psychiatry
Published: October 13, 2021
Long covid-mechanisms, risk factors, and management.
Journal: BMJ (Clinical research ed.)
Published: July 27, 2021
Relationship between astrocyte reactivity, using novel 11C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals.
Journal: Molecular psychiatry
Published: June 25, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026